The course will provide a comprehensive update on the treatment of thoracic malignancies with special emphasis on the multimodality treatment. To that regard there is a wide participation of thoracic surgeons, chest physicians and oncologists.
At the end of the course participants will be able to:
– have a deeper knowledge of diagnostic modalities for thoracic malignancies
– be familiar with the most up to date form of treatment according to stage
– be able to choose and offer the patient several therapeutic modalities with an explanation of advantages and disadvantages
– be confident in drawing a treatment plan involving several specialists and treatment modalities (surgery, oncology and radiotherapy).
December 2, 2020
15:00
15:1515:15
15:30Introduction to the course
MODULE I – EARLY DISEASE
I° SESSION
CHAIR: Marco Scarci, Enrico Ruffini
15:30
15:40Nelson study: what have we learnt and what is left to do?
Tommy D’Amico
15:40
15:50Radiologic diagnosis of lung cancer: when is it enough?
Alexander Patterson
15:50
16:00New bronchoscopic techniques: friend or foe?
Kevin Lau
MODULE I – EARLY DISEASE
II° SESSION
CHAIR: Giuseppe Cardillo, Giulia Veronesi
16:00
16:10Resection vs surveillance for GGOs
Piergiorgio Solli
16:10
16:20Surgery vs SBRT for operable patients: is there a role?
Stefano Arcangeli
16:20
16:30Neoadjuvant treatments for early stage lung cancer: is there a role?
Kostas Papagiannopoulos
MODULE I – EARLY DISEASE
III° SESSION
CHAIR: Federico Raveglia, Lorenzo Rosso
16:30
16:40Where do we draw the line for indications for surgery? The truly inoperable patient
Alex Brunelli
16:40
16:50Ecmo for thoracic surgery
Pierre Emmanuel Falcoz
16:50
17:00How much can we push minimally invasive surgery?
Hasan Batirel
17:00
17:20KEY NOTE SESSION: Uniportal VATS complex anatomic segmentectomies
Diego Gonzalez Rivas
17:20
17:30Q&A
17:30
Closing the firs webinar module
December 3, 2020
15:00
15:15Start of the connection to the webinar
15:15
15:30Introduction to the course
MODULE II – ADVANCED DISEASE
I° SESSION
CHAIR: Diego Cortinovis
15:30
15:40Immunotherapy in resectable NSCLC
Matteo Giaj Levra
15:40
15:50News in immunotherapy world in advanced NSCLC: improving the bar
Nir Peled
15:50
16:00Neoadjuvant strategies in oncogene addicted tumors: is it now the time?
Ignacio Gil-Bazo
MODULE II – ADVANCED DISEASE
II° SESSION
CHAIR: Paolo Bidoli, Diego Cortinovis
16:00
16:10Oncogene addicted tumors: new OMA’s to know
Christian Rolfo
16:10
16:20SCLC a new dawn or the same old refrain
Diego Cortinovis
16:20
16:30Concomitant neoadjuvant chemoRT vs neoadjuvant chemo vs surgery upfront
Tommy D’Amico
MODULE II – ADVANCED DISEASE
III° SESSION
CHAIR: Diego Cortinovis, Christian Rolfo
16:30
16:40Treatment of (un)resactable stage III lung cancer
Federico Cappuzzo
16:40
16:50Oligometastatic disease: when is too much for surgery?
Gaetano Rocco
16:50
17:00Multimodality approach for orphan diseases: MPM and SCLC
Jordi Remon
17:00
17:30Q&A
17:30
Closing of the webinar
5/6 NOVEMBRE 2021 – VIRTUAL EDITION
The multidisciplinary treatment of lung cancer
INFO
International Thoracic Oncology Symposium | Email: info@thoraciconcology.it
ENDORSED BY
DISCLAIMER
The information contained in this website is for general information purposes only. The information is provided by International Thoracic Oncology Symposium and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
© 2020 International Thoracic Oncology Symposium 2020 – Dev by IronMarketing